Siragen Pharmaceuticals seeks to leverage its technological  advances with a strategic development program focused on reaching  significant milestones rapidly and providing early exit and significant returns for its investors. Following a recent seed funding, Siragen is now positioned to raise an “A” round from private and equity investors. Please contact our Vice-President, Business Development at eastman@siragen.com.

Siragen Pharmaceuticals is also open to partnering with large institutions and pharmaceuticals companies for potential joint-ventures, co-development and collaboration. For additional information, please contact our Vice-President, Business Development at eastman@siragen.com.